Wednesday, February 21, 2007

FDA Refuses Pharmacyclics Application

Shares of Pharmacyclics Inc. (PCYC) plunged after the FDA refused to accept the company's application for its lung cancer treatment Xcytrin. The stock price plummeted $1.85 to close at $3.19.

0 Comments:

Post a Comment

<< Home